These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6238991)
1. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. II. Endocrine correlates. London RS; Sundaram G; Manimekalai S; Murphy L; Reynolds M; Goldstein P J Am Coll Nutr; 1984; 3(4):351-6. PubMed ID: 6238991 [TBL] [Abstract][Full Text] [Related]
2. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. London RS; Sundaram GS; Murphy L; Goldstein PJ J Am Coll Nutr; 1983; 2(2):115-22. PubMed ID: 6350402 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. London RS; Murphy L; Kitlowski KE; Reynolds MA J Reprod Med; 1987 Jun; 32(6):400-4. PubMed ID: 3302248 [TBL] [Abstract][Full Text] [Related]
4. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Lombardi I; Luisi S; Quirici B; Monteleone P; Bernardi F; Liut M; Casarosa E; Palumbo M; Petraglia F; Genazzani AR Gynecol Endocrinol; 2004 Feb; 18(2):79-87. PubMed ID: 15195499 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Eriksson E; Sundblad C; Lisjö P; Modigh K; Andersch B Psychoneuroendocrinology; 1992; 17(2-3):195-204. PubMed ID: 1438645 [TBL] [Abstract][Full Text] [Related]
6. [Correlation between neurotransmitters and neurosteroids and premenstrual syndrome patients of Gan-yang ascending syndrome and Gan-qi stagnation syndrome]. Gao H; Xia T; Qiao MQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1503-7. PubMed ID: 23359974 [TBL] [Abstract][Full Text] [Related]
7. The correlation between neurosteroids and neurotransmitters with liver yang rising and liver qi stagnation types of premenstrual syndrome. Gao H; Shang YZ; Xia T; Qiao MQ; Zhang HY; Ma YX Gynecol Endocrinol; 2014; 30(12):913-7. PubMed ID: 25211539 [TBL] [Abstract][Full Text] [Related]
8. The effect of vitamin E on mammary dysplasia: a double-blind study. London RS; Sundaram GS; Murphy L; Manimekalai S; Reynolds M; Goldstein PJ Obstet Gynecol; 1985 Jan; 65(1):104-6. PubMed ID: 3880876 [TBL] [Abstract][Full Text] [Related]
9. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Freeman EW; Rickels K; Sondheimer SJ; Polansky M JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258 [TBL] [Abstract][Full Text] [Related]
10. Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial. Andersen AN; Larsen JF; Steenstrup OR; Svendstrup B; Nielsen J Br J Obstet Gynaecol; 1977 May; 84(5):370-4. PubMed ID: 329858 [TBL] [Abstract][Full Text] [Related]
11. Endocrine parameters and alpha-tocopherol therapy of patients with mammary dysplasia. London RS; Sundaram GS; Schultz M; Nair PP; Goldstein PJ Cancer Res; 1981 Sep; 41(9 Pt 2):3811-3. PubMed ID: 7020937 [TBL] [Abstract][Full Text] [Related]
12. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F; Bélanger A; Cusan L; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308 [TBL] [Abstract][Full Text] [Related]
13. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate. Klove KL; Roy S; Lobo RA Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and treatment of breast symptoms in patients with the premenstrual syndrome. London RS; Sundaram GS; Murphy L; Goldstein PJ J Reprod Med; 1983 Aug; 28(8):503-8. PubMed ID: 6685185 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512 [TBL] [Abstract][Full Text] [Related]
16. Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone. Tommaselli GA; Di Carlo C; Bifulco G; Di Spiezio Sardo A; Pellicano M; Nappi C Clin Endocrinol (Oxf); 2003 Dec; 59(6):716-22. PubMed ID: 14974912 [TBL] [Abstract][Full Text] [Related]
17. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial. Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358 [TBL] [Abstract][Full Text] [Related]
18. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. Nestler JE; Clore JN; Strauss JF; Blackard WG J Clin Endocrinol Metab; 1987 Jan; 64(1):180-4. PubMed ID: 2946716 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. Baker ER; Best RG; Manfredi RL; Demers LM; Wolf GC J Assist Reprod Genet; 1995 Mar; 12(3):205-9. PubMed ID: 8520187 [TBL] [Abstract][Full Text] [Related]
20. Bromocriptine treatment of the premenstrual syndrome. Kullander S; Svanberg L Acta Obstet Gynecol Scand; 1979; 58(4):375-8. PubMed ID: 393053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]